CYTOKINETICS, INCORPORATED Operating Income
CYTOKINETICS, INCORPORATED (CYTK) reported Operating Income of -$179.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED operating income (loss) for the quarter ending 2026-06-30 was -$179.17M.
- CYTOKINETICS, INCORPORATED operating income (loss) for the quarter ending 2026-03-31 was -$183.62M.
- CYTOKINETICS, INCORPORATED operating income (loss) for the quarter ending 2025-12-31 was -$178.37M.
- CYTOKINETICS, INCORPORATED operating income (loss) for the quarter ending 2025-09-30 was -$166.75M.
- CYTOKINETICS, INCORPORATED operating income (loss) for fiscal 2025 was -$612.26M.
- CYTOKINETICS, INCORPORATED operating income (loss) for fiscal 2024 was -$536.25M.
- CYTOKINETICS, INCORPORATED operating income (loss) for fiscal 2023 was -$496.20M.
- CYTOKINETICS, INCORPORATED operating income (loss) for fiscal 2022 was -$324.20M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 167 month | Operating Income (Loss) 170 month | Operating Income (Loss) 173 month | Operating Income (Loss) 176 month | Operating Income (Loss) 179 month | Operating Income (Loss) 182 month | Operating Income (Loss) 185 month | Operating Income (Loss) 188 month | Operating Income (Loss) 191 month | Operating Income (Loss) 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$179.17M 10-Q · filed 2026-08-06 | -$362.79M 10-Q · filed 2026-08-06 | -$541.16M derived: sum of 3 quarters · filed 2026-08-06 | -$707.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2026-03-31 | -$183.62M 10-Q · filed 2026-05-05 | -$361.98M derived: sum of 2 quarters · filed 2026-05-05 | -$528.74M derived: sum of 3 quarters · filed 2026-05-05 | -$640.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-12-31 | -$178.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$345.12M derived: sum of 2 quarters · filed 2026-02-26 | -$456.63M derived: sum of 3 quarters · filed 2026-08-06 | -$612.26M 10-K · filed 2026-02-26 | ||||||||||||
| 2025-09-30 | -$166.75M 10-Q · filed 2025-11-05 | -$278.26M derived: sum of 2 quarters · filed 2026-08-06 | -$433.89M 10-Q · filed 2025-11-05 | -$572.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-06-30 | -$111.51M 10-Q · filed 2026-08-06 | -$267.14M 10-Q · filed 2026-08-06 | -$406.18M derived: sum of 3 quarters · filed 2026-08-06 | -$546.98M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-03-31 | -$155.63M 10-Q · filed 2026-05-05 | -$294.67M derived: sum of 2 quarters · filed 2026-05-05 | -$435.47M derived: sum of 3 quarters · filed 2026-05-05 | -$565.64M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||||
| 2024-12-31 | -$139.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$279.84M derived: sum of 2 quarters · filed 2026-02-26 | -$410.01M derived: sum of 3 quarters · filed 2026-02-26 | -$536.25M 10-K · filed 2026-02-26 | ||||||||||||
| 2024-09-30 | -$140.80M 10-Q · filed 2025-11-05 | -$270.97M derived: sum of 2 quarters · filed 2025-11-05 | -$397.21M 10-Q · filed 2025-11-05 | -$524.63M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2024-06-30 | -$130.17M 10-Q · filed 2025-08-07 | -$256.41M 10-Q · filed 2025-08-07 | -$383.82M derived: sum of 3 quarters · filed 2026-02-26 | -$506.09M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2024-03-31 | -$126.23M 10-Q · filed 2025-05-06 | -$253.65M derived: sum of 2 quarters · filed 2026-02-26 | -$375.92M derived: sum of 3 quarters · filed 2026-02-26 | -$497.97M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2023-12-31 | -$127.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$249.68M derived: sum of 2 quarters · filed 2026-02-26 | -$371.73M derived: sum of 3 quarters · filed 2026-02-26 | -$496.20M 10-K · filed 2026-02-26 | ||||||||||||
| 2023-09-30 | -$122.27M 10-Q · filed 2024-11-07 | -$244.31M derived: sum of 2 quarters · filed 2024-11-07 | -$368.79M 10-Q · filed 2024-11-07 | -$495.82M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-06-30 | -$122.05M 10-Q · filed 2024-08-09 | -$246.52M 10-Q · filed 2024-08-09 | -$373.55M derived: sum of 3 quarters · filed 2025-02-27 | -$481.99M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-03-31 | -$124.47M 10-Q · filed 2024-05-10 | -$251.50M derived: sum of 2 quarters · filed 2025-02-27 | -$359.94M derived: sum of 3 quarters · filed 2025-02-27 | -$370.82M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2022-12-31 | -$127.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$235.47M derived: sum of 2 quarters · filed 2025-02-27 | -$246.34M derived: sum of 3 quarters · filed 2025-02-27 | -$324.20M 10-K · filed 2025-02-27 | ||||||||||||
| 2022-09-30 | -$108.44M 10-Q · filed 2023-11-03 | -$119.31M derived: sum of 2 quarters · filed 2023-11-03 | -$197.17M 10-Q · filed 2023-11-03 | -$218.88M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | -$10.87M 10-Q · filed 2023-08-03 | -$88.73M 10-Q · filed 2023-08-03 | -$110.44M derived: sum of 3 quarters · filed 2024-02-28 | -$179.64M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | -$77.86M 10-Q · filed 2023-05-05 | -$99.56M derived: sum of 2 quarters · filed 2024-02-28 | -$168.76M derived: sum of 3 quarters · filed 2024-02-28 | -$223.56M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | -$21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$90.91M derived: sum of 2 quarters · filed 2024-02-28 | -$145.70M derived: sum of 3 quarters · filed 2024-02-28 | -$186.31M 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | -$69.20M 10-Q · filed 2022-11-04 | -$124.00M derived: sum of 2 quarters · filed 2022-11-04 | -$164.61M 10-Q · filed 2022-11-04 | -$201.02M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2021-06-30 | -$54.80M 10-Q · filed 2022-08-05 | -$95.41M 10-Q · filed 2022-08-05 | -$131.81M derived: sum of 3 quarters · filed 2023-03-01 | -$126.63M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2021-03-31 | -$40.61M 10-Q · filed 2022-05-06 | -$77.02M derived: sum of 2 quarters · filed 2023-03-01 | -$71.83M derived: sum of 3 quarters · filed 2023-03-01 | -$104.19M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2020-12-31 | -$36.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$31.22M derived: sum of 2 quarters · filed 2023-03-01 | -$63.58M derived: sum of 3 quarters · filed 2023-03-01 | -$93.94M 10-K · filed 2023-03-01 | ||||||||||||
| 2020-09-30 | $5.18M 10-Q · filed 2021-11-05 | -$27.17M derived: sum of 2 quarters · filed 2021-11-05 | -$57.54M 10-Q · filed 2021-11-05 | -$81.24M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||||
| 2020-06-30 | -$32.36M 10-Q · filed 2021-08-06 | -$62.72M 10-Q · filed 2021-08-06 | -$86.43M derived: sum of 3 quarters · filed 2022-02-25 | -$110.35M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||||
| 2020-03-31 | -$30.36M 10-Q · filed 2021-05-07 | -$54.07M derived: sum of 2 quarters · filed 2022-02-25 | -$78.00M derived: sum of 3 quarters · filed 2022-02-25 | -$104.71M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||||
| 2019-12-31 | -$23.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$47.63M derived: sum of 2 quarters · filed 2022-02-25 | -$74.35M derived: sum of 3 quarters · filed 2022-02-25 | -$98.87M 10-K · filed 2022-02-25 | ||||||||||||
| 2019-09-30 | -$23.93M 10-Q · filed 2020-11-06 | -$50.64M derived: sum of 2 quarters · filed 2020-11-06 | -$75.16M 10-Q · filed 2020-11-06 | -$96.62M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||||
| 2019-06-30 | -$26.72M 10-Q · filed 2020-08-07 | -$51.23M 10-Q · filed 2020-08-07 | -$72.69M derived: sum of 3 quarters · filed 2021-02-26 | -$90.61M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||||
| 2019-03-31 | -$24.52M 10-Q · filed 2020-05-08 | -$45.98M derived: sum of 2 quarters · filed 2021-02-26 | -$63.89M derived: sum of 3 quarters · filed 2021-02-26 | -$87.30M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||||
| 2018-12-31 | -$21.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$39.37M derived: sum of 2 quarters · filed 2021-02-26 | -$62.78M derived: sum of 3 quarters · filed 2021-02-26 | -$88.92M 10-K · filed 2021-02-26 | ||||||||||||
| 2018-09-30 | -$17.91M 10-Q · filed 2019-11-01 | -$41.33M derived: sum of 2 quarters · filed 2019-11-01 | -$67.46M 10-Q · filed 2019-11-01 | -$103.98M derived: sum of 4 quarters · filed 2019-11-01 | ||||||||||||
| 2018-06-30 | -$23.41M 10-Q · filed 2019-08-09 | -$49.54M 10-Q · filed 2019-08-09 | -$86.07M derived: sum of 3 quarters · filed 2019-08-09 | -$114.50M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||
| 2018-03-31 | -$26.13M 10-Q · filed 2019-05-09 | -$62.66M derived: sum of 2 quarters · filed 2019-05-09 | -$91.08M derived: sum of 3 quarters · filed 2019-05-09 | -$116.28M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||
| 2017-12-31 | -$36.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$64.95M derived: sum of 2 quarters · filed 2019-03-07 | -$90.14M derived: sum of 3 quarters · filed 2019-03-07 | -$113.40M 10-K · filed 2019-03-07 | ||||||||||||
| 2017-09-30 | -$28.42M 10-Q · filed 2018-11-09 | -$53.62M derived: sum of 2 quarters · filed 2018-11-09 | -$76.87M 10-Q · filed 2018-11-09 | -$69.18M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||||
| 2017-06-30 | -$25.19M 10-Q · filed 2018-08-07 | -$48.45M 10-Q · filed 2018-08-07 | -$40.76M derived: sum of 3 quarters · filed 2018-08-07 | -$6.79M derived: sum of 4 quarters · filed 2018-08-07 | ||||||||||||
| 2017-03-31 | -$23.25M 10-Q · filed 2018-05-10 | -$15.56M derived: sum of 2 quarters · filed 2018-05-10 | $18.40M derived: sum of 3 quarters · filed 2018-05-10 | $7.39M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||||
| 2016-12-31 | $7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $41.65M derived: sum of 2 quarters · filed 2018-03-05 | $30.64M derived: sum of 3 quarters · filed 2018-03-05 | $18.69M 10-K · filed 2018-03-05 | ||||||||||||
| 2016-09-30 | $33.97M 10-Q · filed 2017-11-03 | $32.49M 10-Q · filed 2016-11-03 | $22.95M derived: sum of 2 quarters · filed 2017-11-03 | $11.00M 10-Q · filed 2017-11-03 | $9.52M 10-Q · filed 2016-11-03 | $1.98M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-06-30 | -$11.01M 10-Q · filed 2017-08-04 | -$22.96M 10-Q · filed 2017-08-04 | -$31.99M derived: sum of 3 quarters · filed 2018-03-05 | -$40.87M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||||
| 2016-03-31 | -$11.95M 10-Q · filed 2017-05-04 | -$20.98M derived: sum of 2 quarters · filed 2018-03-05 | -$29.86M derived: sum of 3 quarters · filed 2018-03-05 | -$40.45M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||||
| 2015-12-31 | -$9.02M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | -$17.91M derived: sum of 2 quarters · filed 2018-03-05 | -$28.50M derived: sum of 3 quarters · filed 2018-03-05 | -$37.41M 10-K · filed 2018-03-05 | ||||||||||||
| 2015-09-30 | -$8.89M 10-Q/A · filed 2016-12-15 | -$19.48M derived: sum of 2 quarters · filed 2016-12-15 | -$28.39M 10-Q/A · filed 2016-12-15 | -$19.96M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2015-06-30 | -$10.59M 10-Q · filed 2016-08-04 | -$19.50M 10-Q · filed 2016-08-04 | -$11.08M derived: sum of 3 quarters · filed 2017-03-06 | -$17.07M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2015-03-31 | -$8.91M 10-Q · filed 2016-05-05 | -$488.00K derived: sum of 2 quarters · filed 2017-03-06 | -$6.49M derived: sum of 3 quarters · filed 2017-03-06 | -$14.89M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2014-12-31 | $8.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $2.42M derived: sum of 2 quarters · filed 2017-03-06 | -$5.98M derived: sum of 3 quarters · filed 2017-03-06 | -$14.75M 10-K · filed 2017-03-06 | ||||||||||||
| 2014-09-30 | -$6.00M 10-Q · filed 2015-11-05 | -$14.40M derived: sum of 2 quarters · filed 2015-11-05 | -$23.18M 10-Q · filed 2015-11-05 | -$16.74M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||
| 2014-06-30 | -$8.41M 10-Q · filed 2015-08-05 | -$17.18M 10-Q · filed 2015-08-05 | -$10.74M derived: sum of 3 quarters · filed 2016-03-03 | -$23.36M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||
| 2014-03-31 | -$8.77M 10-Q · filed 2015-05-04 | -$2.34M derived: sum of 2 quarters · filed 2016-03-03 | -$14.95M derived: sum of 3 quarters · filed 2016-03-03 | -$30.02M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||
| 2013-12-31 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$6.18M derived: sum of 2 quarters · filed 2016-03-03 | -$21.25M derived: sum of 3 quarters · filed 2016-03-03 | -$33.89M 10-K · filed 2016-03-03 | ||||||||||||
| 2013-09-30 | -$12.61M 10-Q · filed 2014-11-06 | -$27.68M derived: sum of 2 quarters · filed 2014-11-06 | -$40.33M 10-Q · filed 2014-11-06 | -$51.81M derived: sum of 4 quarters · filed 2015-03-06 | -$510.77M 10-Q · filed 2013-11-06 | |||||||||||
| 2013-06-30 | -$15.07M 10-Q · filed 2014-08-07 | -$27.71M 10-Q · filed 2014-08-07 | -$39.20M derived: sum of 3 quarters · filed 2015-03-06 | -$49.28M derived: sum of 4 quarters · filed 2015-03-06 | -$498.16M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | -$12.65M 10-Q · filed 2014-05-07 | -$24.14M derived: sum of 2 quarters · filed 2015-03-06 | -$34.21M derived: sum of 3 quarters · filed 2015-03-06 | -$43.16M derived: sum of 4 quarters · filed 2015-03-06 | -$483.09M 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | -$11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | -$21.56M derived: sum of 2 quarters · filed 2015-03-06 | -$30.52M derived: sum of 3 quarters · filed 2015-03-06 | -$40.46M 10-K · filed 2015-03-06 | -$470.45M 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | -$10.07M 10-Q · filed 2013-11-06 | -$19.03M derived: sum of 2 quarters · filed 2013-11-06 | -$28.97M 10-Q · filed 2013-11-06 | -$40.87M derived: sum of 4 quarters · filed 2014-03-07 | -$458.96M 10-Q · filed 2012-11-07 | |||||||||||
| 2012-06-30 | -$8.96M 10-Q · filed 2013-08-07 | -$18.90M 10-Q · filed 2013-08-07 | -$30.79M derived: sum of 3 quarters · filed 2014-03-07 | -$41.46M derived: sum of 4 quarters · filed 2014-03-07 | -$448.89M 10-Q · filed 2012-08-06 | |||||||||||
| 2012-03-31 | -$9.94M 10-Q · filed 2013-05-08 | -$21.84M derived: sum of 2 quarters · filed 2014-03-07 | -$32.51M derived: sum of 3 quarters · filed 2014-03-07 | -$46.15M derived: sum of 4 quarters · filed 2014-03-07 | -$439.93M 10-Q · filed 2012-05-04 | |||||||||||
| 2011-12-31 | -$11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$22.57M derived: sum of 2 quarters · filed 2014-03-07 | -$36.21M derived: sum of 3 quarters · filed 2014-03-07 | -$47.96M 10-K · filed 2014-03-07 | -$429.99M 10-K · filed 2012-03-13 | |||||||||||
| 2011-09-30 | -$10.67M 10-Q · filed 2012-11-07 | -$24.32M derived: sum of 2 quarters · filed 2012-11-07 | -$36.07M 10-Q · filed 2012-11-07 | -$47.70M derived: sum of 4 quarters · filed 2013-03-15 | -$418.09M 10-Q · filed 2011-11-04 | |||||||||||
| 2011-06-30 | -$13.65M 10-Q · filed 2012-08-06 | -$25.40M 10-Q · filed 2012-08-06 | -$37.03M derived: sum of 3 quarters · filed 2013-03-15 | -$49.60M derived: sum of 4 quarters · filed 2013-03-15 | -$407.43M 10-Q · filed 2011-08-04 | |||||||||||
| 2011-03-31 | -$11.75M 10-Q · filed 2012-05-04 | -$23.38M derived: sum of 2 quarters · filed 2013-03-15 | -$35.95M derived: sum of 3 quarters · filed 2013-03-15 | -$49.10M derived: sum of 4 quarters · filed 2013-03-15 | ||||||||||||
| 2010-12-31 | -$11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$24.20M derived: sum of 2 quarters · filed 2013-03-15 | -$37.35M derived: sum of 3 quarters · filed 2013-03-15 | -$49.63M 10-K · filed 2013-03-15 | ||||||||||||
| 2010-09-30 | -$12.56M 10-Q · filed 2011-11-04 | -$25.72M derived: sum of 2 quarters · filed 2011-11-04 | -$38.00M 10-Q · filed 2011-11-04 | |||||||||||||
| 2010-06-30 | -$13.15M 10-Q · filed 2011-08-04 | -$25.44M 10-Q · filed 2011-08-04 | ||||||||||||||
| 2009-12-31 | $26.09M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |